Gilead Sciences Inc (GILD) Monthly Backtest Results
Backtest Summary
This table summarises how profitable it would have been to have bought this stock at each monthly entry signal. The compound annual growth rate (CAGR) shows the profitability of the trade on an annualised basis.
| Entry Date | Exit Date | Profit or Loss | CAGR |
|---|---|---|---|
| 03 September 2024 | Trade in progress | 53.92% | |
| 01 February 2024 | 01 March 2024 | -7.41% | -62.05% |
| 01 December 2022 | 01 June 2023 | -16.00% | -29.51% |
| 03 January 2022 | 01 March 2022 | -17.02% | -69.72% |
| 01 July 2021 | 01 November 2021 | -5.38% | -15.25% |
| 01 April 2020 | 03 August 2020 | -2.76% | -7.91% |
| 02 January 2020 | 03 February 2020 | 2.55% | 33.27% |
| 04 September 2018 | 01 November 2018 | -6.73% | -36% |
| 01 March 2018 | 01 May 2018 | -6.76% | -34.23% |
| 01 September 2017 | 02 January 2018 | -11.29% | -30.12% |
| Total Return | -16.89% | ||
The monthly data for Gilead Sciences Inc (exchange: XNAS symbol: GILD) was last updated 27 Dec 2025 05:09. Data for this stock is available from 01 Dec 2015 - 26 Dec 2025.
